Depression and Anxiety in Patients with Oropharyngeal Dysphagia Evaluated by Fiberoptic Endoscopic Evaluation of Swallowing (FEES). [PDF]
Ceylan BT, Gürü M.
europepmc +1 more source
Post-extubation dysphagia in the ICU-a narrative review: epidemiology, mechanisms and clinical management (Update 2025). [PDF]
Bertschi D +5 more
europepmc +1 more source
Eating difficulties among Nigerian community-dwelling stroke survivors: prevalence, correlates, and association with quality of life. [PDF]
Ademoyegun AB +7 more
europepmc +1 more source
Early Levodopa Therapy in Tyrosine Hydroxylase Deficiency
Movement Disorders Clinical Practice, EarlyView.
Claudio M. de Gusmao +4 more
wiley +1 more source
Is Dysphagia in Multiple System Atrophy Responsive to Levodopa? Results from a Retrospective Study
Abstract Background Dysphagia remains a major clinical concern in multiple system atrophy (MSA), and so far, lacks relevant treatment options. Objective To systematically assess levodopa‐responsiveness of dysphagia in MSA. Methods 19 MSA‐patients underwent endoscopic swallowing evaluation in Off‐ and On‐state, following an adapted FEES‐levodopa‐test ...
Florin Gandor +10 more
wiley +1 more source
The swallow, a target to follow the restauration of consciousness in acquired brain injury. [PDF]
Lerick AC +6 more
europepmc +1 more source
Blepharospasm in GNAO1 Syndrome May Benefit From Botulinum Toxins
Movement Disorders Clinical Practice, EarlyView.
Eleonora Minacapilli +4 more
wiley +1 more source
Classifying neurogenic dysphagia as a movement disorder. [PDF]
Jones CA +3 more
europepmc +1 more source
ABSTRACT The use of immune checkpoint inhibitors (ICIs) has significantly improved the efficacy of cancer therapy, but their associated immune‐related adverse events (irAEs) can severely compromise treatment safety. This review systematically summarizes the core mechanisms underlying irAEs, which include multi‐organ damage resulting from T‐cell ...
Anqi Lin +8 more
wiley +1 more source

